logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Rosalind Glasspool

Beatson West of Scotland Cancer Centre
H指数:47
被引数:9,338

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differences in First-Line Chemosensitivity Assessed by KELIM in Advanced Serous Ovarian Cancer: Evidence From Western and Japanese Trials in a Gynecologic Cancer InterGroup (GCIG) Meta-analysis

KELIM评估的晚期浆液性卵巢癌一线化疗敏感性差异：源自妇科肿瘤协作组（GCIG）荟萃分析的西方与日本试验证据

International Journal of Gynecological Cancer
IF4.7
2026-06-160
PREAI
Pauline Corbaux; Benoit You; Iain McNeish; Stephen Welch; Anna V. Tinker; Mansoor R. Mirza; Kristina Lindemann; Tatsuo Kagimura; Isabelle L. Ray-Coquard; Fabien Subtil; Julien Péron; Karen Carty; Caroline Kelly; Olivier Colomban; Eleni Karamouza; Adrian Cook; Xavier Paoletti; Rosalind M. Glasspool; Nozomu Yanaihara
Identifying High-Risk Relapse in Early-Stage I–II Ovarian Cancer Using the CA-125 ELIMination rate constant K (KELIM) Score: A GCIG Individual Patient Data Meta-analysis

使用CA-125 ELIMination率常数K (KELIM)评分识别早期I-II期卵巢癌的高复发风险：一项GCIG个体患者数据荟萃分析

International Journal of Gynecological Cancer
IF4.7
2025-10-100
OAAI
Pauline Corbaux; Benoit You; Tatsuo Kagimura; Rosalind M. Glasspool; Iain McNeish; Adrian Cook; Mansoor R. Mirza; Kristina Lindemann; Anna V. Tinker; Stephen Welch; Isabelle L. Ray-Coquard; Fabien Subtil; Olivier Colomban; Julien Péron; Eleni Karamouza; Caroline Kelly; Liz-Anne Lewsley; Xavier Paoletti; Nozomu Yanaihara
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer

Rimel, B.J.; Pujade-Lauraine, E.; Moore, K.; Pfisterer, J.; Han, S.; Cibula, D.; Reyners, A.; Redondo, A.; Papadimitriou, C.; Eitan, R.; 等. 评估聚(ADP-核糖)聚合酶抑制联合免疫疗法用于晚期卵巢癌一线治疗的III期临床试验. Oncologist 2025, 30, oyaf270. [Google Scholar] [CrossRef]

ONCOLOGIST
IF4.2
2025-10-011
OAAI
Rimel, B. J.; Pujade-Lauraine, Eric; Moore, Kathleen; Pfisterer, Jacobus; Han, Sileny; Cibula, David; Reyners, Anna; Redondo, Andres; Papadimitriou, Christos; Eitan, Ram; Pignata, Sandro; Glasspool, Rosalind; Mirza, Mansoor Raza; Bodnar, Lubomir; Duska, Linda; Provencher, Diane; Phaeton, Rebecca; Bains, Manjinder; Coskuncay, Elif; Hardy-Bessard, Anne Claire
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer

Ewing, A.; Meynert, A.; Silk, R.; Aitken, S.; Bendixsen, D.P.; Churchman, M.; Brown, S.L.; Hamdan, A.; Mattocks, J.; Grimes, G.R.; 等. 结构多样性影响高级别浆液性卵巢癌患者生存的分歧轨迹。Nat. Commun. 2025, 16, 5586. [Google Scholar] [CrossRef] [PubMed]

Nature Communications
IF15.7
2025-07-010
OAAI
Ailith Ewing; Alison Meynert; Ryan Silk; Stuart Aitken; Devin P. Bendixsen; Michael Churchman; Stuart L. Brown; Alhafidz Hamdan; Joanne Mattocks; Graeme R. Grimes; Tracy Ballinger; Robert L. Hollis; C. Simon Herrington; John P. Thomson; Kitty Sherwood; Thomas Parry; Edward Esiri-Bloom; Clare Bartos; Ian Croy; Michelle Ferguson; Mairi Lennie; Trevor McGoldrick; Neil McPhail; Nadeem Siddiqui; Rosalind Glasspool; Melanie Mackean; Fiona Nussey; Brian McDade; Darren Ennis; Lynn McMahon; Athena Matakidou; Brian Dougherty; Ruth March; J. Carl Barrett; Iain A. McNeish; Andrew V. Biankin; Patricia Roxburgh; Charlie Gourley; Colin A. Semple
Dostarlimab and niraparib in primary advanced ovarian cancer

多斯塔利姆单抗和尼拉帕利在原发性晚期卵巢癌中的应用

Annals of Oncology
IF65.4
2025-06-020
OAAI
A.-C. Hardy-Bessard; E. Pujade-Lauraine; R.G. Moore; F. Montestruc; A. Redondo; M.R. Mirza; D. Cibula; T.-E. Ciuleanu; L. Gilbert; R. Eitan; F. Zagouri; S. Pignata; R. Glasspool; J. Pfisterer; R. Phaëton; C.K. Anderson; M. Rodrigues; L. Gaba; E. Bakirtzi; J.M. Fauci; E. Kalbacher; F.B. Musa; S. Gorman; L.R. Duska; L. Gladieff; P. Braly; F. Joly; J. Thomes Pepin; I. Ray-Coquard; K.N. Moore
Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status

含体细胞或胚系BRCA和同源重组修复突变状态的铂敏感复发卵巢癌患者接受奥拉帕利维持治疗后的总生存期

BRITISH JOURNAL OF CANCER
IF6.8
2025-03-170
OA
Pignata, Sandro; Oza, Amit; Hall, Geoff; Pardo, Beatriz; Madry, Radoslaw; Cibula, David; Klat, Jaroslav; Montes, Ana; Glasspool, Rosalind; Colombo, Nicoletta; Pete, Imre; Herrero Ibanez, Ana; Romeo, Margarita; Ilieva, Rumyana; Timcheva, Constanta; Di Maio, Massimo; Bashir, Zahid; Taylor, Rosie; Barnicle, Alan; Clamp, Andrew
Difference Of Chemosensitivity Between Western And Japanese Women In First-Line Setting Of Advanced Serous Ovarian Cancer: Data From The MAOV Individual Patient Data Meta-Analysis

西方与日本女性在晚期浆液性卵巢癌一线治疗中的化疗敏感性差异：来自MAOV个体患者数据Meta分析的数据

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-02-010
PRE
Corbaux, Pauline; You, Benoit; Glasspool, Rosalind; Yanaihara, Nozomu; Tinker, Anna, V; Lindemann, Kristina; Ray-Coquard, Isabelle Laure; Mirza, Mansoor Raza; Subtil, Fabien; Colomban, Olivier; Peron, Julien; Karamouza, Eleni; Mcneish, Iain; Kelly, Caroline; Kagimura, Tatsuo; Welch, Stephen; Lewsley, Liz-Anne; Paoletti, Xavier; Cook., Adrian
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors
BMC CANCER
IF3.4
2024-10-240
OAAI
Carucci, Margherita; Clamp, Andrew; Zhou, Cong; Hurt, Chris; Glasspool, Rosalind; Monaghan, Phillip J.; Thirkettle, Sally; Wheatley, Michael; Mahmood, Madia; Narasimham, Monica; Cox, Tracy; Morrison, Hilary; Campbell, Susan; Nelson, Annmarie; Holland-Hart, Daniella; Hopewell-Kelly, Noreen; Thomas, Abin; Porter, Catharine; Slusarczyk, Magdalena; Irving, Alys; Dive, Caroline; Adams, Richard; Jayson, Gordon C.
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ ENGOT-ov38): a phase IIIb trial

先前接受PARP抑制剂 (OReO/ ENGOT-ov38) 治疗的铂敏感复发性卵巢癌患者的维持olaparib再激发: IIIb期试验

ANNALS OF ONCOLOGY
IF65.4
2023-12-0123
OA
Pujade-Lauraine, E.; Selle, F.; Scambia, G.; Asselain, B.; Marme, F.; Lindemann, K.; Colombo, N.; Madryl, R.; Glasspool, R.; Vergote, I.; Korach, J.; Lheureux, S.; Dubot, C.; Oaknin, A.; Zamagni, C.; Heitz, F.; Gladieff, L.; Rubio-Perez, M. J.; Scollo, P.; Blakeley, C.; Shaw, B.; Ray-Coquard, I; Redondo, A.
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first- line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-09-018
OAAI
Corbaux, Pauline; You, Benoit; Glasspool, Rosalind M.; Yanaihara, Nozomu; Tinker, Anna, V; Lindemann, Kristina; Ray-Coquard, Isabelle L.; Mirza, Mansoor R.; Subtil, Fabien; Colomban, Olivier; Peron, Julien; Karamouza, Eleni; McNeish, Iain; Kelly, Caroline; Kagimura, Tatsuo; Welch, Stephen; Lewsley, Liz -Anne; Paoletti, Xavier; Cook, Adrian
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
CANCER RESEARCH
IF16.6
2022-10-0710
OAAI
Ho, Gwo Yaw; Kyran, Elizabeth L.; Bedo, Justin; Wakefield, Matthew J.; Ennis, Darren P.; Mirza, Hasan B.; Vandenberg, Cassandra J.; Lieschke, Elizabeth; Farrell, Andrew; Hadla, Anthony; Lim, Ratana; Dall, Genevieve; Vince, James E.; Chua, Ngee Kiat; Kondrashova, Olga; Upstill-Goddard, Rosanna; Bailey, Ulla-Maja; Dowson, Suzanne; Roxburgh, Patricia; Glasspool, Rosalind M.; Bryson, Gareth; Biankin, Andrew V.; Cooke, Susanna L.; Ratnayake, Gayanie; McNally, Orla; Traficante, Nadia; DeFazio, Anna; Weroha, S. John; Bowtell, David D.; McNeish, Iain A.; Papenfuss, Anthony T.; Scott, Clare L.; Barker, Holly E.
EPIK-O/ENGOT-OV61: Alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study)

EPIK-O/ENGOT-OV61: Alpelisib联合奥拉帕尼与细胞毒性化疗治疗高级别浆液性卵巢癌 (III期研究)

FUTURE ONCOLOGY
IF2.6
2022-09-0616
OA
Konstantinopoulos, Panagiotis A.; Gonzalez-Martin, Antonio; Cruz, Felipe Melo; Friedlander, Michael; Glasspool, Rosalind; Lorusso, Domenica; Marth, Christian; Monk, Bradley J.; Kim, Jae-Weon; Hinson, Patsy; Ajipa, Olga; Pretre, Vincent; Han, Yu; Matulonis, Ursula A.

研究方向

暂未获取到该数据
I
Iain A. McNeish
H 指数:71论文数:781被引数:3.5万
M
Marc T. Goodman
H 指数:109论文数:853被引数:7.5万
U
Usha Menon
H 指数:92论文数:938被引数:4.0万
S
Susan J. Ramus
H 指数:78论文数:761被引数:2.3万
C
Claus Høgdall
H 指数:65论文数:555被引数:1.6万
D
Diether Lambrechts
H 指数:122论文数:1,318被引数:6.9万
F
Florian Heitz
H 指数:55论文数:586被引数:1.0万
E
Estrid Høgdall
H 指数:78论文数:718被引数:2.3万
G
Georgia Chenevix‐Trench
H 指数:115论文数:997被引数:7.0万
W
Weiva Sieh
H 指数:50论文数:266被引数:1.4万